Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:1675-1684
Published online before print March 24, 2008, doi: 10.1161/CIRCULATIONAHA.107.730614
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
117/13/1675    most recent
CIRCULATIONAHA.107.730614v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schunkert, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schunkert, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*SNP*UniGene
Medline Plus Health Information
*Coronary Artery Disease
Related Collections
Right arrow Risk Factors
Right arrow Genetics of cardiovascular disease
Right arrowRelated Article

(Circulation. 2008;117:1675-1684.)
© 2008 American Heart Association, Inc.


Genetics

Repeated Replication and a Prospective Meta-Analysis of the Association Between Chromosome 9p21.3 and Coronary Artery Disease

Heribert Schunkert, MD; Anika Götz, MSc; Peter Braund, MSc; Ralph McGinnis, PhD; David-Alexandre Tregouet, PhD; Massimo Mangino, PhD; Patrick Linsel-Nitschke, MD; Francois Cambien, MD; Christian Hengstenberg, MD; Klaus Stark, PhD; Stefan Blankenberg, MD; Laurence Tiret, PhD; Pierre Ducimetiere, MD; Andrew Keniry, PhD; Mohammed J.R. Ghori, PhD; Stefan Schreiber, MD; Nour Eddine El Mokhtari, MD; Alistair S. Hall, FRCP; Richard J. Dixon, PhD; Alison H. Goodall, PhD; Henrike Liptau, MD; Helen Pollard, MSc; Daniel F. Schwarz, MSc; Ludwig A. Hothorn, PhD; H. -Erich Wichmann, MD; Inke R. König, PhD; Marcus Fischer, MD; Christa Meisinger, MD; Willem Ouwehand, FRCPath; Panos Deloukas, PhD; John R. Thompson, PhD; Jeanette Erdmann, PhD; Andreas Ziegler, PhD; Nilesh J. Samani, FMedSci, for the Cardiogenics Consortium

From Medizinische Klinik II (H.S., A.G., P.L.-N., H.L., J.E.) and Institut für Medizinische Biometrie und Statistik (A.G., D.F.S., I.R.K., A.Z.), Universität zu Lübeck, Lübeck, Germany; Department of Cardiovascular Sciences (P.B., M.M., R.J.D., A.H.G., H.P., N.J.S.) and Department of Health Sciences and Genetics (J.R.T.), Glenfield Hospital, University of Leicester, Leicester, UK; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton (R.M., A.K., M.J.R.G., P.D.), and Department of Haematology, University of Cambridge and National Health Service Blood and Transplant, Cambridge Centre (W.O.), Cambridge, UK; INSERM and Université Pierre et Marie Curie-Paris 6, Paris, France (D.-A.T., F.C., L.T.); Klinik und Poliklinik für Innere Medizin II, Universität Regensburg, Regensburg, Germany (C.H., K.S., M.F.); II. Medizinische Klinik, Johannes Gutenberg University, Mainz, Germany (S.B.); Unité INSERM 780–Université Paris Sud XI, Villejuif, France (P.D.); Institut für Klinische Molekularbiologie, UK-SH, Campus Kiel, Kiel, Germany (S.S., N.E.E.M.); C-NET Group, Leeds Institute for Genetics and Therapeutics, Faculty of Medicine and Health, University of Leeds, Leeds, UK (A.S.H.); Institut für Biostatistik, Leibniz Universität Hannover, Hannover, Germany (L.A.H.); Institut für Epidemiologie, Helmholtz Zentrum München, Deutsches Forschungszentrum für Umwelt und Gesundheit, Neuherberg, Germany (H.-E.W., C.M.); Institute of Medical Informatics, Biometry, and Epidemiology, Ludwig Maximilians University, Munich, Germany (H.-E.W.).

Reprint requests to Dr Heribert Schunkert, Medizinische Klinik II, Universität zu Lübeck, Lübeck, Germany (e-mail heribert.schunkert{at}innere2.uni-luebeck.de); or Dr Nilesh Samani, Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Wing, Glenfield Hospital, Groby Rd, Leicester, LE3 9QP, UK (e-mail njs@le.ac.uk).

Received July 27, 2007; accepted January 29, 2008.

Background— Recently, genome-wide association studies identified variants on chromosome 9p21.3 as affecting the risk of coronary artery disease (CAD). We investigated the association of this locus with CAD in 7 case-control studies and undertook a meta-analysis.

Methods and Results— A single-nucleotide polymorphism (SNP), rs1333049, representing the 9p21.3 locus, was genotyped in 7 case-control studies involving a total of 4645 patients with myocardial infarction or CAD and 5177 controls. The mode of inheritance was determined. In addition, in 5 of the 7 studies, we genotyped 3 additional SNPs to assess a risk-associated haplotype (ACAC). Finally, a meta-analysis of the present data and previously published samples was conducted. A limited fine mapping of the locus was performed. The risk allele (C) of the lead SNP, rs1333049, was uniformly associated with CAD in each study (P<0.05). In a pooled analysis, the odds ratio per copy of the risk allele was 1.29 (95% confidence interval, 1.22 to 1.37; P=0.0001). Haplotype analysis further suggested that this effect was not homogeneous across the haplotypic background (test for interaction, P=0.0079). An autosomal-additive mode of inheritance best explained the underlying association. The meta-analysis of the rs1333049 SNP in 12 004 cases and 28 949 controls increased the overall level of evidence for association with CAD to P=6.04x10–10 (odds ratio, 1.24; 95% confidence interval, 1.20 to 1.29). Genotyping of 31 additional SNPs in the region identified several with a highly significant association with CAD, but none had predictive information beyond that of the rs1333049 SNP.

Conclusion— This broad replication provides unprecedented evidence for association between genetic variants at chromosome 9p21.3 and risk of CAD.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 1621. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. J. Fuster, P. Fernandez, H. Gonzalez-Navarro, C. Silvestre, Y. N. Abu Nabah, and V. Andres
Control of cell proliferation in atherosclerosis: insights from animal models and human studies
Cardiovasc Res, December 3, 2009; (2009) cvp363v2.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Libby, P. M. Ridker, G. K. Hansson, and for the Leducq Transatlantic Network on Atherothro
Inflammation in Atherosclerosis From Pathophysiology to Practice.
J. Am. Coll. Cardiol., December 1, 2009; 54(23): 2129 - 2138.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Newton-Cheh, N. R. Cook, M. VanDenburgh, E. B. Rimm, P. M. Ridker, and C. M. Albert
A Common Variant at 9p21 Is Associated With Sudden and Arrhythmic Cardiac Death
Circulation, November 24, 2009; 120(21): 2062 - 2068.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
J.C. Knight
Genetics and the general physician: insights, applications and future challenges
QJM, November 1, 2009; 102(11): 757 - 772.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
P. Hoppmann, A. Erl, S. Turk, K. Tiroch, J. Mehilli, A. Schomig, A. Kastrati, and W. Koch
No Association of Chromosome 9p21.3 Variation With Clinical and Angiographic Outcomes After Placement of Drug-Eluting Stents
J. Am. Coll. Cardiol. Intv., November 1, 2009; 2(11): 1149 - 1155.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Jarinova, A. F.R. Stewart, R. Roberts, G. Wells, P. Lau, T. Naing, C. Buerki, B. W. McLean, R. C. Cook, J. S. Parker, et al.
Functional Analysis of the Chromosome 9p21.3 Coronary Artery Disease Risk Locus
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1671 - 1677.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
H. Ding, Y. Xu, X. Wang, Q. Wang, L. Zhang, Y. Tu, J. Yan, W. Wang, R. Hui, C.-Y. Wang, et al.
9p21 is a Shared Susceptibility Locus Strongly for Coronary Artery Disease and Weakly for Ischemic Stroke in Chinese Han Population
Circ Cardiovasc Genet, August 1, 2009; 2(4): 338 - 346.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
C. Cluett, M. M. McDermott, J. Guralnik, L. Ferrucci, S. Bandinelli, I. Miljkovic, J. M. Zmuda, R. Li, G. Tranah, T. Harris, et al.
The 9p21 Myocardial Infarction Risk Allele Increases Risk of Peripheral Artery Disease in Older People
Circ Cardiovasc Genet, August 1, 2009; 2(4): 347 - 353.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. R. Sipido, A. Tedgui, S. D. Kristensen, G. Pasterkamp, H. Schunkert, M. Wehling, P. G. Steg, W. Eisert, F. Rademakers, B. Casadei, et al.
Identifying needs and opportunities for advancing translational research in cardiovascular disease
Cardiovasc Res, August 1, 2009; 83(3): 425 - 435.
[Full Text] [PDF]


Home page
JAMAHome page
P. Elliott, J. C. Chambers, W. Zhang, R. Clarke, J. C. Hopewell, J. F. Peden, J. Erdmann, P. Braund, J. C. Engert, D. Bennett, et al.
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
JAMA, July 1, 2009; 302(1): 37 - 48.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
A. Brautbar, C. M. Ballantyne, K. Lawson, V. Nambi, L. Chambless, A. R. Folsom, J. T. Willerson, and E. Boerwinkle
Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Reclassification of Coronary Heart Disease Risk and Implications for Lipid-Modifying Therapy in the Atherosclerosis Risk in Communities Study
Circ Cardiovasc Genet, June 1, 2009; 2(3): 279 - 285.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Yamagishi, A. R. Folsom, W. D. Rosamond, E. Boerwinkle, and for the ARIC Investigators
A genetic variant on chromosome 9p21 and incident heart failure in the ARIC study
Eur. Heart J., May 2, 2009; 30(10): 1222 - 1228.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Coronary Artery Disease Consortium
Large Scale Association Analysis of Novel Genetic Loci for Coronary Artery Disease
Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 774 - 780.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
J. G. Smith, O. Melander, H. Lovkvist, B. Hedblad, G. Engstrom, P. Nilsson, J. Carlson, G. Berglund, B. Norrving, and A. Lindgren
Common Genetic Variants on Chromosome 9p21 Confers Risk of Ischemic Stroke: A Large-Scale Genetic Association Study
Circ Cardiovasc Genet, April 1, 2009; 2(2): 159 - 164.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. M.K. Williams, A. M. Carter, B. Kato, M. Falchi, L. Bathum, G. Surdulescu, K. O. Kyvik, A. Palotie, T. D. Spector, P. J. Grant, et al.
Identification of Quantitative Trait Loci for Fibrin Clot Phenotypes: The EuroCLOT Study
Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 600 - 605.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
J. P.A. Ioannidis
Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular Risk Factors by Genome-Wide Association Markers
Circ Cardiovasc Genet, February 1, 2009; 2(1): 7 - 15.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
N. P. Paynter, D. I. Chasman, J. E. Buring, D. Shiffman, N. R. Cook, and P. M. Ridker
Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3
Ann Intern Med, January 20, 2009; 150(2): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. P.A. Ioannidis
Personalized Genetic Prediction: Too Limited, Too Expensive, or Too Soon?
Ann Intern Med, January 20, 2009; 150(2): 139 - 141.
[Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
N. J. Samani and H. Schunkert
Chromosome 9p21 and Cardiovascular Disease: The Story Unfolds
Circ Cardiovasc Genet, December 1, 2008; 1(2): 81 - 84.
[Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
B. D. Horne, J. F. Carlquist, J. B. Muhlestein, T. L. Bair, and J. L. Anderson
Association of Variation in the Chromosome 9p21 Locus With Myocardial Infarction Versus Chronic Coronary Artery Disease
Circ Cardiovasc Genet, December 1, 2008; 1(2): 85 - 92.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
G. S. Sagoo, I. Tatt, G. Salanti, A. S. Butterworth, N. Sarwar, M. van Maarle, J. W. Jukema, B. Wiman, J. J. P. Kastelein, A. M. Bennet, et al.
Seven Lipoprotein Lipase Gene Polymorphisms, Lipid Fractions, and Coronary Disease: A HuGE Association Review and Meta-Analysis
Am. J. Epidemiol., December 1, 2008; 168(11): 1233 - 1246.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
K. Musunuru and S. Kathiresan
HapMap and Mapping Genes for Cardiovascular Disease
Circ Cardiovasc Genet, October 1, 2008; 1(1): 66 - 71.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J. B. van der Net, D. M. Oosterveer, J. Versmissen, J. C. Defesche, M. Yazdanpanah, B. E. Aouizerat, E. W. Steyerberg, M. J. Malloy, C. R. Pullinger, J. J.P. Kastelein, et al.
Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia
Eur. Heart J., September 2, 2008; 29(18): 2195 - 2201.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.-K. Heng
Genome-wide association studies of coronary artery disease: have the results of replication studies been replicable?
Eur. Heart J., September 2, 2008; 29(18): 2189 - 2190.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. J. Samani, O. T. Raitakari, K. Sipila, M. D. Tobin, H. Schunkert, M. Juonala, P. S. Braund, J. Erdmann, J. Viikari, L. Moilanen, et al.
Coronary Artery Disease-Associated Locus on Chromosome 9p21 and Early Markers of Atherosclerosis
Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1679 - 1683.
[Abstract] [Full Text] [PDF]